Eltrombopag, an oral platelet growth factor, for treatment of chronic immune thrombocytopenic purpura (ITP): A randomized, double-blind, placebo-controlled trial

James B. Bussel, Gregory Cheng, Mansoor Saleh, Bethan Psaila, Lidia Kovaleva, Nicole Stone, Bhabita Mayer, Julian Jenkins, Andrew Provan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)66-67
Number of pages2
JournalJournal of Supportive Oncology
Issue number4 SUPPL. 2
Publication statusPublished - Apr 2007

Cite this